|
|
||||||||
Articles |
Department of Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands.
OBJECTIVE: To investigate whether or not a change in dialysate interleukin-8 (IL-8) concentration precedes the onset of clinically overt peritonitis and is significant in the recruitment of granulocytes during continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis. DESIGN: CAPD patients stored their overnight effluent at 4 degrees C, which was routinely thrown away after 2 days. If peritonitis developed, patients delivered their effluent of the preceding two nights and the peritonitis effluent for analysis. A control study was performed 1 to 3 months after recovery. Dialysate samples were analyzed for number of cells, differential cell count, IL-8 and elastase concentrations, and their neutrophil chemoattractive capacity. In addition, serum samples during peritonitis were analyzed for IL-8 concentrations. RESULTS: Ten peritonitis episodes in 7 patients were analyzed. Numbers of neutrophils and levels of dialysate IL-8 and elastase started to increase 4 to 12 hours before the first peritonitis effluent. The dialysate/serum IL-8 ratio was 423.5 during peritonitis and 7.0 in the postperitonitis controls. There was a significant correlation between the number of neutrophils and IL-8 concentration in the dialysate. The in vitro neutrophil chemotaxis was increased toward the peritonitis effluents, as compared to control effluents. Incubation of the peritonitis effluents with anti-IL-8 monoclonal antibody blocked the increase in neutrophil chemotaxis above control levels by an average of 26.7%. CONCLUSION: IL-8 is produced in the peritoneal cavity during CAPD treatment and may mediate part of the neutrophil recruitment and degranulation in the initial phase of a CAPD peritonitis.
This article has been cited by other articles:
![]() |
J.-H. Park, Y.-G. Kim, M. Shaw, T.-D. Kanneganti, Y. Fujimoto, K. Fukase, N. Inohara, and G. Nunez Nod1/RICK and TLR Signaling Regulate Chemokine and Antimicrobial Innate Immune Responses in Mesothelial Cells J. Immunol., July 1, 2007; 179(1): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Flessner The transport barrier in intraperitoneal therapy Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. A. Welten, M. Zareie, J. van den Born, P. M. ter Wee, C. G. Schalkwijk, B. A. J. Driesprong, F. P. J. Mul, P. L. Hordijk, R. H. J. Beelen, and L. H. P. Hekking In vitro and in vivo models for peritonitis demonstrate unchanged neutrophil migration after exposure to dialysis fluids Nephrol. Dial. Transplant., April 1, 2004; 19(4): 831 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Robson, R. M. McLoughlin, J. Witowski, P. Loetscher, T. S. Wilkinson, S. A. Jones, and N. Topley Differential Regulation of Chemokine Production in Human Peritoneal Mesothelial Cells: IFN-{{gamma}} Controls Neutrophil Migration Across the Mesothelium In Vitro and In Vivo J. Immunol., July 15, 2001; 167(2): 1028 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Witowski, A. Thiel, R. Dechend, K. Dunkel, N. Fouquet, T. O. Bender, J. M. Langrehr, G. M. Gahl, U. Frei, and A. Jorres Synthesis of C-X-C and C-C Chemokines by Human Peritoneal Fibroblasts : Induction by Macrophage-Derived Cytokines Am. J. Pathol., April 1, 2001; 158(4): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |